From academic spin-off to clinical testing in medical device sensor technology
Franz Bozsak will be talking about his role as the CEO and co-founder of Sensome. Sensome developed a breakthrough technology that turns medical devices into connected healthcare devices. Founded in 2014, this young spin-off from Ecole polytechnique has developed impedance-based micro-sensors that coupled with machine learning algorithms allow the identification of biological tissues in real time. Integrated with medical devices, this information can provide physicians with critical insights when making treatment decisions for their patients.
Sensome is currently developing a smart neurovascular guidewire that can determine the nature of the blood clot blocking a brain artery causing a stroke. Knowing the type of clot causing the stroke can potentially speed-up the process of re-establishing blood flow to the patient’s brain. First clinical testing of this device is planned for 2018. Beyond stroke, Sensome’s sensor technology can be deployed in other medical fields, such as interventional cardiology or oncology.
Franz Bozsak obtained a M.S. in Aerospace Engineering from the University of Stuttgart and a Ph.D. from Ecole polytechnique in Biomedical Engineering on the optimization of stents. He is a graduate of the Stanford Ignite/Polytechnique business program. In 2014, he co-founded Sensome and has since brought together a team of renowned scientists, engineers and doctors to realize his vision of connected medical devices. He was named Innovator Under 35 by the MIT Technology Review in 2016.
Date: Tuesday 30 January
Venue: Roberts Building, G08, Sir David Davies LT (map)
18.00 – 19.00: Industry Seminar
19.00 – 20.00: Drinks reception